Menu Search
Equities

Hogy Medical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HGYMF:PKL

Hogy Medical Co Ltd

Actions
  • Price (USD)42.50
  • Today's Change0.00 / 0.00%
  • Shares traded500.00
  • 1 Year change--
  • Beta0.1589
Data delayed at least 15 minutes, as of Dec 23 2025 19:01 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hogy Medical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical consumables and other products, as well as related services. The Company is engaged in the manufacture and sale of medical consumables, medical devices, and medical nonwoven fabric products. The Company provides sterilized supplies, surgical nonwoven fabric products, remanufactured single-use medical devices, endoscope holders, and endoscopic surgical sponges for medical professionals.

  • Revenue in JPY (TTM)37.84bn
  • Net income in JPY222.00m
  • Incorporated1961
  • Employees1.41k
  • Location
    Hogy Medical Co Ltd19F, Akasaka Green Cross, 2-4-6, AkasakaMINATO-KU 107-8615JapanJPN
  • Phone+81 362291300
  • Fax+81 362291350
  • Websitehttps://www.hogy.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.